FDA Drug Recalls

Recalls / Class II

Class IID-0567-2022

Product

Alprazolam Tablets, USP 2.0 mg, packaged in a) 100-count bottles (NDC 67253-903-10), b) 500-count bottles (NDC 67253-903-50), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

Affected lot / code info
Lot #: a) 19C002A, Exp. Date 03/2022; 19E012A, 19E013A, Exp. Date 05/2022. b) 19C100B, Exp. Date 04/2022; 19E001B, 19E002B, Exp. Date 05/2022.

Why it was recalled

cGMP Deviations

Recalling firm

Firm
ANI Pharmaceuticals, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
210 W Main St, N/A, Baudette, Minnesota 56623-2467

Distribution

Quantity
70,788 bottles
Distribution pattern
Nationwide within the United States

Timeline

Recall initiated
2022-02-15
FDA classified
2022-02-17
Posted by FDA
2022-02-23
Terminated
2022-10-25
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0567-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls